Abstract
BackgroundPancreatic ductal adenocarcinoma (PDAC) is resistant to many available therapies including immunotherapy because of its highly complex tumor microenvironment (TME). PDAC TME consists of a significant proportion of stromal cells,...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have